Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2092L |
Amitifadine free base
DOV 21947,DOV-21947,DOV21,947,DOV21947,DOV 21,947,DOV-21,947 |
||
Amitifadine(DOV-21947, EB-1010) is an inhibitor of the so-called triple reuptake or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) and is an antidepressant drug candidate. Amitifadine reduces binge drinking and negative affect in an animal m | |||
T69275 |
DOV-102677
|
||
DOV-102677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a triple reuptake inhibitor, or serotonin-norepinephrine-dopamine reuptake inhibitor. It is the-enantiomer of DOV-216,303, and its-enantiomer is DOV-21,947. |